Health
AstraZeneca's Heart Drug Trial Fails to Impress, Raises Industry Concerns
By Editor • August 28, 2026 • 1 min read
AstraZeneca's heart disease drug trial failed to show benefits for patients already on stabilizers, impacting the broader ATTR-CM market.
Read more